The new fundraising and education platform Grow Medicine provides people interested in iboga, ayahuasca, toad, peyote, and mushrooms the opportunity to...
Big money is starting to take a more public interest in the science of psychedelics, which makes even the biggest skeptics take notice. The post Big...
As Oregon heads towards the first legal psilocybin system in the country, activists and educators come together to discuss the program ahead of next week's...
Whether you’re a seasoned trader making money with penny stocks or just… The post Penny Stocks To Buy: The Good, Bad, & Ugly & 3 To...
The article Rising Spirit: Sisters in Psychedelics was originally published on Microdose. I once asked my physical trainer begrudgingly “how long am...
Psychologist Ralph Hood’s study of serpent handling and mysticism helped legitimize the study of psychedelics. So why doesn't he want them approved for...
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday that the previously released positive topline data The post MindMed...
The article MindMed Faces Tough IP Questions (and Publishes Positive Trial Results) was originally published on Microdose. MindMed’s been in the news...
Source: Daniel Patrick Martin / Shutterstock.com MindMed (NASDAQ:MNMD) stock is on the move Wednesday following positive data from a Phase II clinical...
The article The Medicalization of Sacred Plant Medicines was originally published on Microdose. Like many, I’ve watched the recent resurgence of interest...